The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development
Open accessAbstract
TDP-43 is a DNA/RNA-binding protein implicated in multiple steps of transcriptional and post-transcriptional regulation of gene expression. Alteration of this multifunctional protein is associated with a number of neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positive inclusions. Whereas a pathological link to neurodegenerative disorders has been established, the cellular and physiological functions of TDP-43 remain unknown. In this study, we show that TDP-43 is a nuclear protein with persistent high-level expression during embryonic development and with progressively decreased protein levels during postnatal development. In mice where the TDP-43 gene (Tardbp) was disrupted using a gene trap that carries a beta-galactosidase marker gene, heterozygous (Tardbp(+/-)) mice are fertile and healthy, but intercrosses of Tardbp(+/-) mice yielded no viable homozygotic null (Tardbp(-/-)) mice. Indeed, Tardbp(-/-) embryos die between 3.5 and 8.5 days of development. Tardbp(-/-) blastocysts grown in cell culture display abnormal expansion of their inner cell mass. The pattern of beta-galactosidase staining at E9.5 Tardbp(+/-) embryos is predominantly restricted to the neuroepithelium and remains prominent in neural progenitors at E10.5-12.5. TDP-43 is detected in spinal cord progenitors and in differentiated motor neurons as well as in the dorsal root ganglia at E12.5. Beta-galactosidase staining of tissues from adult Tardbp(+/-) mice shows widespread expression of TDP-43, including prominent levels in various regions of the central nervous system afflicted in neurodegenerative disorders. These results indicate that TDP-43 is developmentally regulated and indispensible for early embryonic development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALS-like phenotypes are seen in mice with partial depletion of TDP43 by RNA interference, or with targeted deletion of Tdp43 in motor neurons”
From The neurogenetics of alternative splicing (2016) · cites this paper as [164]
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
hnRNP PROTEINS AND THE BIOGENESIS OF mRNA
Dreyfuss, G., Matunis, M. J., Piñol-Roma, S., & Burd, C. G. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.001445 · Cited by 1,558
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Ou, S.-H. I., Wu, F. K., Harrich, D., Garcı́a-Martı́nez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 762
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Buratti, E., Dörk, T., Zuccato, E., Pagani, F., Romano, M., & Baralle, F. E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1774 · Cited by 633
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Zhang, Y., Xu, Y.-F., Cook, C. N., Gendron, T. F., Roettges, P. S., Link, C. D., Lin, W.-L., Tong, J., Castanedes‐Casey, M., Ash, P. E. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900688106 · Cited by 614
Rethinking ALS: The FUS about TDP-43
Lagier‐Tourenne, C., & Cleveland, D. W. (2009) · Cell · doi:10.1016/j.cell.2009.03.006 · Cited by 596
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–371 of 371
Myopathic aggregation-prone variants in the TDP-43 prion-like domain: genetics paving the way
Pereira, P. E., Bleecker, J. D., Bogaert, E., & Dermaut, B. (2025) · Brain · doi:10.1093/brain/awaf076 · Cited by 3
Wu, J., Guo, J., Wu, J., Song, J., Xu, J., Lin, Y., Huang, C., Shi, C., Li, J., Li, C., et al. (2025) · Brain · doi:10.1093/brain/awaf330 · Cited by 5
Neurotrophic Therapy for ALS/MND
Rogers, M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_34 · Cited by 3
The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis
Wenzhi, Y., Xiangyi, L., & Dongsheng, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34963 · Cited by 3
Harji, Z. A., Rampal, C. J., Rodríguez, E. C., Légaré, V. P., Lissouba, A., Semmler, S., Liao, M., Ross, J. P., Rouleau, G. A., Velde, C. V., et al. (2025) · Annals of Neurology · doi:10.1002/ana.78012 · Cited by 3
Chen, Q., Zhou, J., Huang, C., Huang, B., Bi, F., Zhou, H., & Xiao, B. (2018) · Current Neurovascular Research · doi:10.2174/1567202615666180109161541 · Cited by 3
Roberson, E. D., & Kao, A. W. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.007 · Cited by 3
TDP-43: [GU]-ardian of the transcriptome
Sinha, I. R., Atkinson, A. L., Irwin, K. E., Ling, J. P., & Wong, P. C. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00944-2 · Cited by 2
Ferraiuolo, L., Meyer, K., & Kaspar, B. K. (2013) · InTech eBooks · doi:10.5772/56487 · Cited by 3
Feng, L., Sharma, A., Wang, Z., Muresanu, D. F., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., Wiklund, L., & Sharma, H. S. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_3 · Cited by 2
Molecular basis of the autoregulatory mechanism of motor neuron-related splicing factor 30
Izumikawa, K., Shida, T., Onodera, Y., Tashima, Y., Miyao, S., Suda, T., Suda, Y., Kamimura, R., Nagai, M., Sugihara, M., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110522 · Cited by 2
Importance of the Q/N-rich segment for protein stability of endogenous mouse TDP-43
Sato, T., Oda, K., Sakai, S., Kato, R., Yamamori, S., Itakura, M., Kodera, Y., Nishizawa, M., Sasaoka, T., Onodera, O., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19153-0 · Cited by 2
Sung, W., Kim, J.-A., Kim, Y. S., Park, J., Oh, K., Sung, J., Kim, Y.-E., Kim, Y.-E., & Kim, S. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-45593-3 · Cited by 2
Flores, B. N., Li, X., Martinez, J., Beg, A. A., & Barmada, S. J. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3236488 · Cited by 1
Xu, X., Zhang, C., Jiang, J., Xin, M., & Hao, J. (2021) · Research Square · doi:10.21203/rs.3.rs-762288/v1 · Cited by 2
Maurel, C., Scherer, N. M., Hogan, A. L., Vidal-Itriago, A., Don, E. K., Radford, R. A. W., Chapman, T. R., Cull, S., Vourc’h, P., Chung, R. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.14.503569 · Cited by 2
Barriers to Novel Therapeutics in Amyotrophic Lateral Sclerosis
Kobeleva, X., & Petri, S. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.66 · Cited by 1
Uncovering Critical Roles for RNA in Neurodegeneration.
Ayala, Y. M. (2023) · PubMed Central · Cited by 1
Dinh, T. T. H., IMURA, C., Shiokawa, M., Ayabe, S., Yoshiki, A., Inoue, H., & Amano, T. (2025) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.25-0061 · Cited by 1
Sergeeva, O. S., Neklesova, M. V., Reushev, V. A., Artemov, A. V., Константинович, Т. К., Константинович, Т. К., Uversky, V. N., & Fonin, A. V. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152808 · Cited by 2
Miller, M. R., Dykstra, M. M., & Barmada, S. J. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199846 · Cited by 1
Enhancer RNA-mediated transcriptional regulation of TDP-43 during early neural lineage specification
Jang, Y., Lee, H., Oh, M., Moon, J., Kim, S. S., Han, J., Park, J.-L., & Kim, S.-K. (2026) · Animal Cells and Systems · doi:10.1080/19768354.2026.2643998 · Cited by 1
Targeting TDP-43 in sporadic amyotrophic lateral sclerosis
Estevez‐Fraga, C., Álvarez‐Velasco, R., Afroz, T., Costa, M. R., Jovičić, A., Yeh, F. L., McColgan, P., Malaspina, A., & McCampbell, A. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14023-5 · Cited by 1
Neurotoxicity and ALS: Insights into Pathogenesis
Vucic, S., & Kiernan, M. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_138-1 · Cited by 1
Heterogeneous Nuclear Ribonucleoproteins In Amyotrophic Lateral Sclerosis: What Do We Know?
Moujalled, D., & White, A. R. (2014) · Future Neurology · doi:10.2217/fnl.14.7 · Cited by 1
TDP-43 is essential for Eph receptor-class-specific spinal motor axon trajectory into the limb
Kao, T., Wang, C., Hsu, T., Wu, Y., Chuang, J.-Y., Huang, C.-C. S., & Hsieh, C. T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.10.006 · Cited by 1
Amyotrophic Lateral Sclerosis: From Mechanisms to Current, Emerging, and Alternative Therapeutics
Kioutchoukova, I. P. (2023) · Med Discoveries · doi:10.52768/2993-1142/1059 · Cited by 1
Mechanisms of FUS-mediated motor neuron degeneration in amyotrophic lateral sclerosis
Lyashchenko, A. K. (2015) · doi:10.7916/d8jq0zv1 · Cited by 1
TDP-43 Depletion: Mechanism of Neuronal Cell Death in ALS
Kitamura, A. (2018) · Future Neurology · doi:10.2217/fnl-2018-0010 · Cited by 1
TDP-43 y su incidencia en demencias degenerativas
Ure, J. A. (2020) · Neurología Argentina · doi:10.1016/j.neuarg.2020.07.001 · Cited by 1
A systems biology approach to understand the role of TDP-43 in amyotrophic lateral sclerosis
Haque, M. M. U., Anwar, M. S., Malik, M. Z., Singh, R. K. B., Verma, N., & Sharma, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820066-7.00006-0 · Cited by 1
Neurotrophic Therapy for ALS/MND
Fowler, M., Shepheard, S. R., & Rogers, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_34 · Cited by 1
Neurotoxicity and ALS: Insights into Pathogenesis
Vucic, S., & Kiernan, M. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_138 · Cited by 1
Frontotemporal Lobar Degeneration with TDP‐43 Pathology
Mackenzie, I. R., & Neumann, M. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch41 · Cited by 1
Dykstra, M. M., Weskamp, K., Gómez, N., Waksmacki, J., Tank, E. M. H., Glineburg, M. R., Snyder, A. G., Pinarbasi, E. S., Bekier, M. E., Li, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.02.601776 · Cited by 1
Elucidating the Role of TDP-43 in the Pathogenesis of Amyotrophic Lateral Sclerosis
Jauregui, M. (2012) · TSpace (University of Toronto)
Cheng, W. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2js4j
Involvement of endoplasmic reticulum stress in TDP-43-linked neurodegenerative disease
Walker, A. K. (2014) · Postdoc Journal · doi:10.14304/surya.jpr.v2n6.2
Baldwin, K. R. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Electrophysiological biomarkers for the study of new therapeutic strategies for motoneuron disease
Mancuso, R. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The role of ALS associated genes and c-Jun in neurodegeneration
Acosta‐Saltos, A. (2016) · UCL Discovery (University College London)
Autonomous and motor disorders
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.005
TDP-43 Pathology: Elucidation of Mechanisms and Treatment with Tyrosine Kinase Inhibition
Heyburn, L. (2017) · DigitalGeorgetown (Georgetown University Library)
Investigation of the intercellular transmission of α-synuclein, amyloid-β and TDP-43
Sackmann, C. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-160318
Relationship Between TDP-43 Toxicity and Aggregation in Saccharomyces Cerevisiae
Aguilar, M. A. (2018) · Digital Commons - DU (University of Denver)
New lessons on TDP-43 from the killifish N. furzeriPreprint
Louka, A., Bagnoli, S., Rupert, J., Esapa, B., Tartaglia, G. G., Cellerino, A., Pastore, A., & Tozzini, E. T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.04.429704
Structural dissection of TDP-43
Kumar, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820066-7.00001-1
Importance of the Q/N-rich Segment for Protein Stability and Activity of Endogenous Mouse TDP-43Preprint
Sato, T., Oda, K., Sakai, S., Kato, R., Yamamori, S., Itakura, M., Kodera, Y., Nishizawa, M., Sasaoka, T., Onodera, O., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1113360/v1
Neurotrophic Therapy for ALS/MND
Fowler, M., Shepheard, S. R., & Rogers, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_34-1
Characterization of the Human TARDBP Gene PromoterPreprint
Baralle, M., & Romano, M. (2020) · Research Square · doi:10.21203/rs.3.rs-110373/v1
Gordon, D., & Talbot, K. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.008
Theme 07 - Pre-Clinical Therapeutic Strategies
(2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2120683
Nagorska, A., Zaucker, A., Lambert, F. R. P., Inman, A., Toral-Pérez, S., Gorodkin, J., Wan, Y., Smutny, M., & Sampath, K. (2023) · Development · doi:10.1242/dev.201657
Assessment of an allelic series of mouse TDP43 mutations
Ricketts, T. C. (2012) · UCL Discovery (University College London)
Implication des macrophages périphériques dans la Sclérose latérale Amyotrophique
Chiot, A. (2018) · theses.fr (ABES) · doi:10.70675/e3d90f5az237az4722zbff2z9c99590e826b
Novel FUS and CHCHD10 models to investigate pathogenic mechanisms in Amyotrophic Lateral Sclerosis
Bourefis, A.-R. (2019) · theses.fr (ABES) · doi:10.70675/45ab8515z9859z430fzb472z306dd61206c8
Comprendre et modéliser la Sclérose Latérale Amyotrophique à début précoce
Muratet, F. (2022) · theses.fr (ABES) · doi:10.70675/9a7778aaz88c7z40b1z92d3zaf5699b86a09
Yatoui, D. (2022) · theses.fr (ABES) · doi:10.70675/e3620ccez2ea7z43f2za0dcz257a72021b17
TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging
Benatar, M., Barmada, S., Jicha, G. A., Lagier‐Tourenne, C., Gregory, J., Al‐Chalabi, A., Boeve, B. F., Jack, C. R., Seeley, W. W., Maragakis, N. J., et al. (2026) · JAMA Neurology · doi:10.1001/jamaneurol.2026.2812 · Cited by 1
TDP-43 overexpression induces cellular dysfunction and ALS-associated transcriptional changes
DeSando, S. A., McClay, K., Banks, A. N., Cheung, M., Reitz, A. B., & Freeman, K. B. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00324-y
TDP-43 and ALS - what's wrong with my membranes?
Dahlhaus, R., Yalcin, I., Tischer, J., & Braun, R. J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107630
RNA –Protein Reciprocity and the Limits of RBP Buffering
Doxakis, E. (2026) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70065
HeLa-S3 RNA-seq Dataset for Training - chr11 only based on GSE136366
Umer, H. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.18462431
Interrogating the role of splicing factors in Huntington’s Disease
Kooner, G. S. (2015) · Leicester Research Archive (University of Leicester)
Metadata
- Authors
- Sephton, C. F., Good, S. K., Atkin, S., Dewey, C. M., Mayer, P., Herz, J., & Yu, G.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Yu, Gang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 285
- Issue
- 9
- Pages
- 6826-6834
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2825476
- OpenAlex
- W2069350252
- Cited by
- 370
- References
- 31
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 12 · 2023: 22 · 2022: 30 · 2021: 24 · 2020: 17 · 2019: 23 · 2018: 25 · 2017: 20 · 2016: 17 · 2015: 17 · 2014: 32 · 2013: 30 · 2012: 25
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG023104, R01AG029547, R01AG023104)
- National Heart, Lung, and Blood Institute (R37HL063762)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TDP-43, TARDBP, embryonic development, gene trap, conditional knockout mice, neural progenitor cells, neuroepithelium, motor neurons, dorsal root ganglia, developmental regulation, neurodegenerative diseases, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, ubiquitin-positive inclusions
- MeSH terms
- Animals, Animals, Newborn, Blastocyst, Central Nervous System, DNA-Binding Proteins, Heterozygote, Homozygote, Neurons, Stem Cells, Tissue Distribution, Gene Expression Regulation, Developmental, Neurodegenerative Diseases, Embryonic Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review